Misspellings or “miscellings”-non-verifiable cell lines in cancer research publications
Danielle J. Oste,Pranujan Pathmendra,Reese A. K. Richardson,Gracen Johnson,Yida Ao,Maya D. Arya,Naomi R. Enochs,Muhammed Hussein,Jinghan Kang,Aaron Lee,Jonathan J. Danon,Guillaume Cabanac,Cyril Labbé,Amanda Capes Davis,Thomas Stoeger,Jennifer A. Byrne
DOI: https://doi.org/10.1101/2024.02.29.582220
2024-03-06
Abstract:Reproducible laboratory research relies on correctly identified reagents. We have previously described human gene research papers with wrongly identified nucleotide sequence reagent(s), including papers studying . Manually verifying reagent identities in more recent papers found 20/36 (56%) and 6/36 (17%) papers with misidentified nucleotide sequence reagent(s) and human cell line(s), respectively. We also found 5 cell line identifiers in two papers with wrongly identified nucleotide sequences and cell lines, and 18 identifiers published elsewhere that did not correspond to indexed cell lines. These cell line identifiers were described as non-verifiable, as their identities appeared uncertain. Studying 420 papers that mentioned 8 different non-verifiable cell line identifier(s) found 235 papers (56%) that appeared to refer to BGC-803, BSG-803, BSG-823, GSE-1, HGC-7901, HGC-803 and/or MGC-823 as independent cell lines. We could not find publications describing how these cell lines were established, and they were not indexed in claimed externally accessible cell line repositories. While some papers stated that STR profiles had been generated for BGC-803, GSE-1 and/or MGC-823 cells, no STR profiles were identified. In summary, non-verifiable human cell lines represent new challenges to research reproducibility and require further investigation to clarify their identities.
Cancer Biology